Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > News After The Close
View:
Post by gonefishing2022 on Sep 24, 2024 7:55pm

News After The Close

Not A Big Rasie but enough to get them to the fall and then they will do another before BTD and everything will be fine. All will be fine just Time
Comment by Beano349 on Sep 24, 2024 9:54pm
The worst one yet...better hurry or we will be out of time. 
Comment by reconsider on Sep 25, 2024 10:52am
I expected a release combo closed PP + preBTD status. Will we hear something before next Tuesday? 
Comment by DJDawg on Sep 25, 2024 11:00am
I hate to say but since pre-BTD isn't a true FDA thing I think that the best we can hope for is something along the lines of BTD submitted or pending ( which would imply that pre-BTD was a pass as you don't do BTD without that go ahead).
Comment by reconsider on Sep 25, 2024 11:47am
I agree, but so much anticipation has been put by management on preBTD that a little checkpoint would be encouraging and maybe even allow for a little price appreciation...
Comment by DJDawg on Sep 25, 2024 11:49am
Totally agree. Some kind of affirmation or confidence would be great.
Comment by Tapps21 on Sep 25, 2024 1:06pm
Just think of what a two dollar SP could do for a lot of us. Would it changed my life significantly no but  I could breathe a lot easier. The literature and documentation from the company that has been released over the last two months should have big Pharma drooling, you would think. The money situation bothers me, but is out of our hands and we have to leave it to management.
Comment by chry200030 on Sep 25, 2024 1:21pm
Two dollars?  A quick run to $2 is coming very soon.  The cure for cancer is worth a whole lot more. $2 is not even close. The chase will soon begin. 
Comment by reconsider on Sep 25, 2024 1:38pm
2USD is x15 from where we are standing. That itself would be an spectacular jump and I wouldn't be expecting much more appreciation after that without any other MAJOR news... I'll be happy with a x7 by Q1 2025 after 8+ years of journey across the laser desert... 
Comment by Alamir1111 on Sep 25, 2024 1:42pm
That's a  good  assesment The directors of the Company have agreed to grant an aggregate of 12,340,000 stock options to directors, officers and employees pursuant to the Company's stock option plan. The options granted are exercisable at a price of $CAN 0.25 per common share, vest over a three-years period and expire five years from the date of the grant. 
Comment by Alamir1111 on Sep 25, 2024 1:48pm
Nice On closing, the Corporation issued an aggregate of 2,720,000 Units at a price of $CAN 0.20 per Unit for aggregate gross proceeds of $CAN 544,000.
Comment by Alamir1111 on Sep 25, 2024 1:51pm
So they manage to sell 2.7 mil units but they get a 12 mil bonus nice
Comment by 2b7f6fab on Sep 25, 2024 8:43pm
You need to keep in mind that the 12 million options granted were to replace the 10 million options that expired a week or two ago.  Of course mgmt is going to replace them.  That's how the game works.  If you don't understand that you shouldn't be investing.  Current share count is approximately 240 million share o/s, 20 million options and 34 million warrants ...more  
Comment by Dumbeldorfwhite on Sep 25, 2024 8:50pm
This post has been removed in accordance with Community Policy
Comment by 1357councilrock on Sep 25, 2024 9:26pm
Younairhead! Options are not free. And many of the most successful companies aroud have used them. Please stop telling us how stupid you are, it is getting stale and boring.
Comment by Dumbeldorfwhite on Sep 25, 2024 10:41pm
Actually that's incorrect they are either free, since they didn't earn it or have it tied to any sort of performance measures, OR they have to pay 25 cents. Either way screammmmms cowardice. Imagine how much more confident this board would be if the options were at say 75 cents or hell 1 dollar. No guts on this team. Time for an overhaul.
Comment by Dumbeldorfwhite on Sep 25, 2024 10:43pm
Furthermore, no one forces the exercising of them look at all the ones that expired from management. Those were all free, they paid nothing and got nothing.
Comment by riverrrow on Sep 25, 2024 9:54pm
The insiders will have to pay 25 cents to exercise these options whereas a handful of investors just picked up a bunch of shares at 20 cents in the pp that just closed.  And the insiders don't dare sell their shares unless the company gets bought out, otherwise they suffer the wrath of some lividly jealous shareholders.  GLTA.
Comment by Alamir1111 on Sep 25, 2024 9:58pm
Each Unit consists of one common share of the Company ("Common Share") and one common share purchase warrant ("Warrant"). Each Warrant entitles the holder to acquire an additional Common Share at an exercise price of $CAN 0.30 per share for a period of 5 years following the date of issuance.
Comment by Dumbeldorfwhite on Sep 25, 2024 10:45pm
Heck yeah I wish I could work, suffer a 40 % decline in productivity or whatever you want to call it, then get granted a boat load of stock options. Seems nice.
Comment by gltainv on Sep 26, 2024 8:15am
if I could I'd sign on too lol, I think this is probably the last chance or bust tbh 
Comment by Alamir1111 on Sep 25, 2024 9:49pm
Nice  10 mil f up now get a 12 mill for good job
Comment by enriquesuave on Sep 25, 2024 10:39pm
With 34 million warrants, if SP hits over 50 cents, most should get excercised bringing in about $10 Million cash.  Warrants are priced at 25, 28, 30 and 35 cents.  IMHO
Comment by Dumbeldorfwhite on Sep 25, 2024 10:47pm
Except all that exercising of that many options will sink the SP right back down. That's 15 ish percent of the total share float almost hahahahaha
Comment by Mikee3003 on Sep 25, 2024 5:18pm
Don't kid yourself Tapps, if big pharma were drooling with all the woopie doo news releases of late they would snap us up in a heartbeat.....yet here we sit with a stock price that indicates end of the road is more likely than the kool aid gangs prediction of $2.00!!!!
Comment by Tapps21 on Sep 25, 2024 6:55pm
Yeah, I agree. Sort of losing a little faith. But then again, the penny stocks are like pulling the handle on a slot machine and I'm just hoping for one lucky break. Chry2000 thinks so lol.  The literature is just to good to not lead anywhere positive.  glta 
Comment by CancerSlayer on Sep 25, 2024 9:58pm
Big Pharma generally wants to see at least 1 BTD in hand for a single indication with unmet need that has a decent market size (1B+) & additional growth potential.  If we are granted a BTD, our ACT certainly fits that criteria.   However, a single BTD for a single indication won't get us to $2...very unlikely on this exchange imo.  I'd be happy to see us reach $0.50 to  ...more  
Comment by Alamir1111 on Sep 25, 2024 10:12pm
 Guess that is realistic  Cc
Comment by enriquesuave on Sep 25, 2024 10:46pm
It will be hard to value BTD as CGON has BTD for a single indication and is valued at $2.5- 3 Billion USD..If we hit $2 USD, that would be $480 million MC.  Still dirt cheap next to CGON  
Comment by Alamir1111 on Sep 25, 2024 11:00pm
Enrique you forgot to mention 200 million in their bank account 
Comment by Alamir1111 on Sep 25, 2024 11:03pm
Second Quarter 2024 Financial Highlights Cash Position: Cash and cash equivalents and marketable securities as of June 30, 2024, were $552.9 million, compared with $566.5 million as of March 31, 2024. Based on cash, cash equivalents and marketable securities as of June 30, 2024, and current operating plans, the Company expects its cash runway to be sufficient to fund operations through 2027.
Comment by Alamir1111 on Sep 25, 2024 11:08pm
Previous post was for cgon this Is for ibrx ImmunityBio Announces $470 Million Equity and Debt Financing From Founder, Dr. Patrick Soon-Shiong and Nant Entities
Comment by Alamir1111 on Sep 25, 2024 11:32pm
Funny thing is Cgon and ibrx never talk about violating rats or killing petri dish viruses
Comment by DeathXray33 on Sep 26, 2024 6:49am
SLICK-CON ; A proud member of the "Never-Ending Scrub-a-Dub family of drugs. ------------------------------------------------------------ "Median duration of response (DOR) was not reached. ------------------------------------------------------------" TRAEs occurred in 70 patients (62.5%). The most common TRAEs (10%) were bladder spasm, pollakiuria, dysuria, micturition urgency, and ...more  
Comment by Mikee3003 on Sep 26, 2024 8:39am
Comparing BTD between TLT and CGON is like comparing a potatoe and a head of lettuce, both are vegtables but the similarities end there.  CGON has a rock star status leadership team, they have excellent cash resourses, they are on a real exchange, they have a zip code in lieu of a postal code, etc etc etc....... TLT on the other hand.........
Comment by enriquesuave on Sep 26, 2024 9:26am
BTD will give them the same FDA recognition period, Then cash and deals  will come in
Comment by Lesalpes29 on Sep 26, 2024 10:12am
TLT only have the best act and they are proving it. Matter of time Mike.
Comment by Lesalpes29 on Sep 26, 2024 10:33am
Of course venture exchange is not the best place to be. But I have seen stock reaching over 1B and more on the venture. Matter of good NR. GL
Comment by DeathXray33 on Sep 26, 2024 1:45pm
It would be great to use for Dogs. I sure could of used it for my 15 yr old. I liked him better than people, especially family members...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250